Dr Reddy's Laboratories EPS - Earnings per Share 2010-2024 | RDY

Dr Reddy's Laboratories earnings per share (EPS) for the twelve months ending September 30, 2024 was $0.62, a 14.17% decline year-over-year.

  • Dr Reddy's Laboratories EPS for the quarter ending September 30, 2024 was $0.04, a 83.18% decline year-over-year.
  • Dr Reddy's Laboratories 2024 annual EPS was $0.8, a 21.52% increase from 2023.
  • Dr Reddy's Laboratories 2023 annual EPS was $0.66, a 76.47% increase from 2022.
  • Dr Reddy's Laboratories 2022 annual EPS was $0.37, a 23.03% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Dr Reddy's Laboratories EPS - Earnings per Share 2010-2024 | RDY

  • Dr Reddy's Laboratories EPS for the quarter ending September 30, 2024 was $0.04, a 83.18% decline year-over-year.
  • Dr Reddy's Laboratories 2024 annual EPS was $0.8, a 21.52% increase from 2023.
  • Dr Reddy's Laboratories 2023 annual EPS was $0.66, a 76.47% increase from 2022.
  • Dr Reddy's Laboratories 2022 annual EPS was $0.37, a 23.03% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M